The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CLOVER HEALTH INVESTMENTS CO | COM CL A | 18914F103 | 1,556 | 210,639 | SH | SOLE | 210,639 | 0 | 0 | ||
| ISHARES TR | CORE S&P US VLU | 464287663 | 52,465 | 740,195 | SH | SOLE | 740,195 | 0 | 0 | ||
| ISHARES TR | RUS 2000 VAL ETF | 464287630 | 66,343 | 414,052 | SH | SOLE | 414,052 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 1,094 | 34,100 | SH | SOLE | 34,100 | 0 | 0 | ||
| VANGUARD INDEX FDS | VALUE ETF | 922908744 | 47,119 | 348,077 | SH | SOLE | 348,077 | 0 | 0 | ||